Edition:
United Kingdom

Accelerate Diagnostics Inc (AXDX.OQ)

AXDX.OQ on NASDAQ Stock Exchange Capital Market

19.30USD
17 May 2019
Change (% chg)

-- (--)
Prev Close
$19.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
105,561
52-wk High
$24.70
52-wk Low
$10.25

Latest Key Developments (Source: Significant Developments)

Accelerate Diagnostics Q1 Loss Per Share $0.40
Thursday, 9 May 2019 

May 9 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.40.Q1 SALES $1.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $2.1 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.41 -- REFINITIV IBES DATA.  Full Article

Accelerate Diagnostics Qtrly Net Loss Per Share $0.41
Tuesday, 6 Nov 2018 

Nov 6 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS REPORTS Q3 2018 FINANCIAL RESULTS.Q3 SALES $1.3 MILLION VERSUS $828,000.Q3 REVENUE VIEW $2.9 MILLION -- THOMSON REUTERS I/B/E/S.QTRLY NET LOSS PER SHARE $0.41.Q3 EARNINGS PER SHARE VIEW $-0.41 -- THOMSON REUTERS I/B/E/S.  Full Article

Accelerate Diagnostics announces pricing of $150 mln notes offering
Friday, 23 Mar 2018 

March 23 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS, INC. ANNOUNCES PRICING OF $150 MILLION CONVERTIBLE NOTES OFFERING.‍PRICING OF $150.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 2.50% CONVERTIBLE SENIOR NOTES DUE 2023​.ACCELERATE DIAGNOSTICS- ‍AN ENTITY AFFILIATED WITH ONE OF ACCELERATE DIAGNOSTICS'S DIRECTORS HAS AGREED TO PURCHASE AN AGGREGATE OF $30 MILLION OF NOTES​.‍SALE OF NOTES TO INITIAL PURCHASERS EXPECTED TO RESULT IN ABOUT $145.6 MILLION IN NET PROCEEDS TO ACCELERATE DIAGNOSTICS​.  Full Article

Accelerate Diagnostics Announces $150 Mln Convertible Notes Offering
Thursday, 22 Mar 2018 

March 22 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS INC. ANNOUNCES $150 MILLION CONVERTIBLE NOTES OFFERING.ACCELERATE DIAGNOSTICS - INTENTION TO OFFER $150.0 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2023.ACCELERATE DIAGNOSTICS INC - ‍EXPECTS TO USE PART OF PROCEEDS OF OFFERING TO PAY PREPAYMENT AMOUNT OF THE PREPAID FORWARD.ACCELERATE DIAGNOSTICS - EXPECTS TO ENTER PRIVATELY NEGOTIATED PREPAID FORWARD WITH AFFILIATE OF ONE OF INITIAL PURCHASERS OF NOTES.ACCELERATE DIAGNOSTICS INC - ‍WILL PURCHASE ITS COMMON STOCK FOR SETTLEMENT ON OR AROUND MARCH 15, 2023​.  Full Article

Accelerate Diagnostics Qtrly Net Loss $0.27 Per Share
Thursday, 15 Feb 2018 

Feb 15 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS REPORTS Q4 AND FULL-YEAR FINANCIAL RESULTS FOR 2017.SEES FY 2018 REVENUE $21 MILLION TO $30 MILLION.Q4 SALES $2.1 MILLION.QTRLY NET LOSS $0.27 PER SHARE.Q4 EARNINGS PER SHARE VIEW $-0.32, REVENUE VIEW $2.4 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Accelerate Diagnostics reports Q3 loss per share $0.31
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics Inc reports q3 2017 financial results.Q3 loss per share $0.31.Q3 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S.  Full Article

Plaintiffs dismiss class action appeal against Accelerate Diagnostics
Wednesday, 13 Sep 2017 

Sept 13 (Reuters) - Accelerate Diagnostics Inc :Plaintiffs dismiss class action appeal against Accelerate Diagnostics.Says ‍court signed order dismissing plaintiffs' appeal of class action lawsuit filed against accelerate,certain of co's executives​.Says ‍shortly before appeal was scheduled to be argued, plaintiffs/appellants voluntarily requested that case be dismissed​.  Full Article

Accelerate Diagnostics reports Q2 loss per share $0.31
Thursday, 3 Aug 2017 

Aug 3 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics reports Q2 2017 financial results, doubles revenue generating placements.Q2 loss per share $0.31.Q2 earnings per share view $-0.30 -- Thomson Reuters I/B/E/S.  Full Article